Background The higher hospitalisation rates of those aged 0–19 years (referred to herein as
'children') observed since the emergence of the immune-evasive SARS-CoV-2 Omicron …

Background To date, more than 761 million confirmed SARS-CoV-2 infections have been
recorded globally, and more than half of all children are estimated to be seropositive …

Objective COVID-19 can rarely lead to severe illness in pediatric patients. The aim of this
study was to determine if severe outcomes in pediatric COVID-19 have changed over the …

Methods| This population-based cohort study prospectively included patients aged 0 to 17
years with MIS-C from all 18 Danish pediatric departments. Patients were diagnosed from …

Disclosures: C. Flores reported grants from Instituto de Salud Carlos III, Spanish Ministry of
Science and Innovation, and Cabildo Insular de Tenerife outside the submitted work. J …

Background Although severe acute COVID-19 is rare in children, SARS-CoV-2 infection can
trigger the novel post-infectious condition multisystem inflammatory syndrome in children …

Coronavirus disease 2019 (COVID-19) resulted in a global pandemic and has overwhelmed
health care systems worldwide. In this scientific statement, we describe the epidemiology …

Methods| We leveraged the US National COVID Cohort Collaborative (N3C) 5 and a
pipeline we built for a National Institutes of Health–funded pediatric COVID-19 dashboard6 …

OBJECTIVES There is limited evidence on whether the relative severity of coronavirus
disease 2019 (COVID-19) in children and adolescents differs for different severe acute …

SARS-CoV-2 infection for most children results in mild or minimal symptoms, though in rare
cases severe disease can develop, including a multisystem inflammatory syndrome (MIS-C) …